Evidence born from ASCOT trial – still important after 15 years
The paper presents the overview evolution of hypertension identification and treatment during last 15 years after publication of ASCOT trial (AngloScandinavian Cardiac Outcomes Trial) results. It discusses possible mechanism of more significant cardiovascular risk reduction in amlodipine/ perindopri...
Main Author: | O. P. Rotar |
---|---|
Format: | Article |
Language: | Russian |
Published: |
InterMedservice
2021-09-01
|
Series: | Евразийский Кардиологический Журнал |
Subjects: | |
Online Access: | https://www.heartj.asia/jour/article/view/6282 |
Similar Items
-
COMPARATIVE EFFECTIVENESS OF FIXED-DOSE COMBINATIONS OF LISINOPRIL/AMLODIPINE AND ENALAPRIL/HYDROCHLOROTHIAZIDE
by: S. V. Nedogoda, et al.
Published: (2013-04-01) -
THE NEW FIXED COMBINATION OF AMLODIPINE AND RAMIPRIL IN THE TREATMENT OF HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2015-09-01) -
Two strategies for arterial hypertension treatment in patients with secondary chronic pyelonephritis
by: M. E. Statsenko, et al.
Published: (2011-08-01) -
Effectiveness and safety of the full-dose combination therapy with perindopril A and indapamide (10 mg/2,5 mg) in patients with arterial hypertension
by: M. G. Glezer, et al.
Published: (2012-10-01) -
Study of clinical effect of original and generic amlodipines in arterial hypertension with obesity: results of randomized cross-over study
by: M. G. Bubnova, et al.
Published: (2016-10-01)